ASMBS Statement on Cleveland Clinic Study

Newswise — NEWBERRY, FL – Nov. 11, 2021– A new Cleveland Clinic study shows that patients with obesity and advanced fatty liver disease who had bariatric surgery (weight-loss surgery) significantly lowered their risk for severe liver disease and serious cardiovascular disease, including heart attack and stroke, compared to patients who did not have the surgery. The study was published online today in JAMA.

Researchers found bariatric surgery was associated…

Read More

Senators Cassidy and Carper Call for Medicare to Cover Obesity Drugs Amid COVID-19 Pandemic

Read More

Statement on metabolic and bariatric surgery during COVID-19 pandemic.

Read More

Evidence-based prediction tool designed to help patients decide between metabolic surgery and standard medical therapy.

Read More

Patients who have surgery before obesity progresses to severe stages may achieve even greater health benefits.

Read More

New study compares differences in cancer risk reduction among weight-loss surgery patients

Read More

Patients with history of heart disease reduce their risk by half

Read More

Overweight and obesity associated with an increased risk of 13 types of cancer

Read More

Patients with severe obesity who get weight-loss surgery cut their spending on diabetes medications by nearly 65 percent and spending on high blood pressure medications by more than a third three to six months after the operation, according to new research from Rush Medical College in Chicago presented here at an American Society for Metabolic and Bariatric Surgery (ASMBS) national clinical symposium on obesity prevention, treatment and research.

Read More

Metabolic or bariatric surgery was significantly more effective than medical management in treating type 2 diabetes in patients with milder forms of obesity, according to new research presented here at an American Society for Metabolic and Bariatric Surgery (ASMBS) national clinical symposium on obesity prevention, treatment and research.

Read More